PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31436113-0	2019	PML with dimethyl fumarate-No convincing case against natalizumab.	Dimethyl Fumarate	9-26	PML nuclear body scaffold	Homo sapiens	0-3	
31436127-0	2019	PML with dimethyl fumarate-No role for natalizumab?	Dimethyl Fumarate	9-26	PML nuclear body scaffold	Homo sapiens	0-3	
29985084-5	2019	The adjusted odds ratio of PML for each drug was as follows; natalizumab 115.72 (95% CI; 83.83, 159.74), fingolimod 4.98 (3.64, 6.81) followed by dimethyl fumarate 1.77 (1.2, 2.62) and rituximab 3.22 (1.07, 9.72).	Dimethyl Fumarate	146-163	PML nuclear body scaffold	Homo sapiens	27-30	
29985084-8	2019	CONCLUSION: The reporting proportion of PML was relatively higher in natalizumab followed by fingolimod, dimethyl fumarate and rituximab.	Dimethyl Fumarate	105-122	PML nuclear body scaffold	Homo sapiens	40-43	
27606353-0	2016	Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate.	Dimethyl Fumarate	63-80	PML nuclear body scaffold	Homo sapiens	9-12	
28283109-4	2017	Fingolimod and dimethyl fumarate have also been unquestionably associated with a risk of PML in the MS population.	Dimethyl Fumarate	15-32	PML nuclear body scaffold	Homo sapiens	89-92	
26798867-0	2016	More on PML in Patients Treated with Dimethyl Fumarate.	Dimethyl Fumarate	37-54	PML nuclear body scaffold	Homo sapiens	8-11	
27343070-0	2016	PML during dimethyl fumarate treatment of multiple sclerosis: How does lymphopenia matter?	Dimethyl Fumarate	11-28	PML nuclear body scaffold	Homo sapiens	0-3	
26789899-0	2016	More on PML in Patients Treated with Dimethyl Fumarate.	Dimethyl Fumarate	37-54	PML nuclear body scaffold	Homo sapiens	8-11	
26798868-0	2016	More on PML in Patients Treated with Dimethyl Fumarate.	Dimethyl Fumarate	37-54	PML nuclear body scaffold	Homo sapiens	8-11	
26244326-0	2015	PML in Patients Treated with Dimethyl Fumarate.	Dimethyl Fumarate	29-46	PML nuclear body scaffold	Homo sapiens	0-3	
26789900-0	2016	More on PML in Patients Treated with Dimethyl Fumarate.	Dimethyl Fumarate	37-54	PML nuclear body scaffold	Homo sapiens	8-11	
25853764-0	2015	PML in a patient without severe lymphocytopenia receiving dimethyl fumarate.	Dimethyl Fumarate	58-75	PML nuclear body scaffold	Homo sapiens	0-3	
25853765-0	2015	PML in a patient with lymphocytopenia treated with dimethyl fumarate.	Dimethyl Fumarate	51-68	PML nuclear body scaffold	Homo sapiens	0-3	
25382392-9	2015	Appendix to the abstract: Subsequent to the acceptance of this article for publication, the manufacturer has notified physicians of the death of one patient from PML complicating use of DMF in the DEFINE study extension (ENDORSE).	Dimethyl Fumarate	186-189	PML nuclear body scaffold	Homo sapiens	162-165	
23614604-0	2013	PML in a patient treated with dimethyl fumarate from a compounding pharmacy.	Dimethyl Fumarate	30-47	PML nuclear body scaffold	Homo sapiens	0-3